These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9466538)

  • 21. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
    Johnson S; Griego SD; Pfarr DS; Doyle ML; Woods R; Carlin D; Prince GA; Koenig S; Young JF; Dillon SB
    J Infect Dis; 1999 Jul; 180(1):35-40. PubMed ID: 10353858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.
    Luchsinger V; Piedra PA; Ruiz M; Zunino E; Martínez MA; Machado C; Fasce R; Ulloa MT; Fink MC; Lara P; Avendaño LF
    Clin Infect Dis; 2012 Apr; 54(7):905-12. PubMed ID: 22238168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Med Virol; 2004 Jun; 73(2):295-9. PubMed ID: 15122807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.
    Tristram DA; Welliver RC; Mohar CK; Hogerman DA; Hildreth SW; Paradiso P
    J Infect Dis; 1993 Jan; 167(1):191-5. PubMed ID: 8418166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
    Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
    J Virol; 2017 May; 91(10):. PubMed ID: 28275185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.
    Habibi MS; Jozwik A; Makris S; Dunning J; Paras A; DeVincenzo JP; de Haan CA; Wrammert J; Openshaw PJ; Chiu C;
    Am J Respir Crit Care Med; 2015 May; 191(9):1040-9. PubMed ID: 25730467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
    Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
    J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization of respiratory syncytial virus after cell attachment.
    Osiowy C; Anderson R
    J Virol; 1995 Feb; 69(2):1271-4. PubMed ID: 7815504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.
    Yamazaki H; Tsutsumi H; Matsuda K; Nagai K; Ogra PL; Chiba S
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2115-9. PubMed ID: 8046418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immunity to respiratory syncytial virus in young and elderly adults.
    Terrosi C; Di Genova G; Martorelli B; Valentini M; Cusi MG
    Epidemiol Infect; 2009 Dec; 137(12):1684-6. PubMed ID: 19366492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.
    Gonzalez IM; Karron RA; Eichelberger M; Walsh EE; Delagarza VW; Bennett R; Chanock RM; Murphy BR; Clements-Mann ML; Falsey AR
    Vaccine; 2000 Mar; 18(17):1763-72. PubMed ID: 10699324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.
    Piedra PA; Grace S; Jewell A; Spinelli S; Hogerman DA; Malinoski F; Hiatt PW
    Pediatr Infect Dis J; 1998 Mar; 17(3):217-24. PubMed ID: 9535249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
    Murphy BR; Graham BS; Prince GA; Walsh EE; Chanock RM; Karzon DT; Wright PF
    J Clin Microbiol; 1986 Jun; 23(6):1009-14. PubMed ID: 3754878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
    Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A primate model of respiratory syncytial virus infection.
    Babu PG; Selvan A; Christuraj S; David J; John TJ; Simoes EA
    Indian J Exp Biol; 1998 Aug; 36(8):758-62. PubMed ID: 9838875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
    Weltzin R; Traina-Dorge V; Soike K; Zhang JY; Mack P; Soman G; Drabik G; Monath TP
    J Infect Dis; 1996 Aug; 174(2):256-61. PubMed ID: 8699052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.
    Forster J; Maier O; Löbbert J; Kaufmehl K; Streckert HJ; Werchau H
    Infection; 1996; 24(6):407-11. PubMed ID: 9007586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.